Jeffrey W. Sherman, Director at Larimar Therapeutics, holds 5.00K shares in Larimar Therapeutics (Ticker: LRMR), holds 224.59K shares in Xeris Pharmaceuticals (Ticker: XERS), holds 0.00 shares in Horizon Therapeutics (Ticker: HZNP). Most recently, Jeffrey W. Sherman Bought ― shares of Larimar Therapeutics on Mar 02, 2026 for an estimated value of $25.00K.
What is the percentage of profitable transactions made by Jeffrey W. Sherman?
The percentage of profitable transactions made by Jeffrey W. Sherman is 25%.
What is the average return per transaction made by Jeffrey W. Sherman?
The average return per transaction made by Jeffrey W. Sherman is 5.10%.
What stocks does Jeffrey W. Sherman hold?
Jeffrey W. Sherman holds: LRMR, HZNP, SBBP, XERS, INSYQ stocks.
What was Jeffrey W. Sherman’s latest transaction?
Jeffrey W. Sherman latest transaction was an Informative Buy of $25.00K.
What was Jeffrey W. Sherman's most profitable transaction?
Jeffrey W. Sherman’s most profitable transaction was an Informative Buy of XERS stock on November 29, 2023. The return on the trade was 77.70%.
What is Jeffrey W. Sherman's role in Larimar Therapeutics?
Jeffrey W. Sherman's role in Larimar Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.